353 related articles for article (PubMed ID: 16894299)
21. [Treatment outcomes in patients with unfavorable histologic type of endometrial carcinoma].
Litvinova TM; Kosenko IA
Vopr Onkol; 2006; 52(1):89-91. PubMed ID: 16715712
[TBL] [Abstract][Full Text] [Related]
22. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
23. Recurrent endometrial cancer.
Del Carmen MG; Boruta DM; Schorge JO
Clin Obstet Gynecol; 2011 Jun; 54(2):266-77. PubMed ID: 21508696
[TBL] [Abstract][Full Text] [Related]
24. Rare gynecologic malignancies.
Schink JC; Lurain JR
Curr Opin Obstet Gynecol; 1991 Feb; 3(1):78-90. PubMed ID: 1652301
[TBL] [Abstract][Full Text] [Related]
25. [Clinico-pathological study of uterine papillary serous carcinoma].
Yamasaki M; Okamoto E; Nobunaga T; Tanaka F; Hisamatsu K; Ohama K; Kirimoto K
Gan No Rinsho; 1987 Jun; 33(6):667-72. PubMed ID: 3599474
[TBL] [Abstract][Full Text] [Related]
26. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
27. GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma.
Idrees MT; Schlosshauer P; Li G; Burstein DE
Histopathology; 2006 Jul; 49(1):75-81. PubMed ID: 16842248
[TBL] [Abstract][Full Text] [Related]
28. Hybrid endometrial carcinoma with short non-villous papillae and serous papillary carcinoma.
Box A; Raj G; Otton G; Bonaventura A; Scurry J
Pathology; 2010 Jan; 42(1):97-9. PubMed ID: 20025494
[No Abstract] [Full Text] [Related]
29. The role of radiation therapy in locally advanced endometrial cancer.
Anderson PR
Semin Radiat Oncol; 2006 Jul; 16(3):152-7. PubMed ID: 16814155
[TBL] [Abstract][Full Text] [Related]
30. [Serous papillary cancer of the endometrium].
Karseladze AI
Arkh Patol; 1987; 49(8):30-5. PubMed ID: 3675216
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous metastasis of papillary serous uterine cancer.
Elit L; Lukka H; Friedman E
Gynecol Oncol; 2001 Jul; 82(1):208-11. PubMed ID: 11426989
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
33. [Treatment strategies for endometrial cancer].
Deppe G; Baumann P
Zentralbl Gynakol; 2004 Oct; 126(5):306-11. PubMed ID: 15478048
[TBL] [Abstract][Full Text] [Related]
34. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
Rabban JT; Zaloudek CJ
Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
[TBL] [Abstract][Full Text] [Related]
35. Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma.
Lee KR; Belinson JL
Am J Surg Pathol; 1991 Oct; 15(10):965-73. PubMed ID: 1928552
[TBL] [Abstract][Full Text] [Related]
36. Metastatic uterine papillary serous carcinoma to the pericardium.
Ramirez PT; Ramondetta LM; Burke TW; Gershenson DM; Brewer MA
Gynecol Oncol; 2001 Oct; 83(1):135-7. PubMed ID: 11585425
[TBL] [Abstract][Full Text] [Related]
37. Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
Woolas RP; Williams K; McCartney AJ
Gynecol Oncol; 1994 Mar; 52(3):395-401. PubMed ID: 8157198
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma.
Sagr ER; Denschlag D; Kerim-Dikeni A; Stanimir G; Gitsch G; Gilbert L
Anticancer Res; 2007; 27(2):1213-7. PubMed ID: 17465265
[TBL] [Abstract][Full Text] [Related]
39. Papillary serous carcinoma of the peritoneum following endometrial cancer.
Rose PG; Reale FR
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):980-3. PubMed ID: 1923247
[TBL] [Abstract][Full Text] [Related]
40. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
